pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest
The DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.
Abstract
Transforming growth factor-beta (TGF-beta) inhibits cell proliferation by inducing a G1-phase cell cycle arrest. Normal progression through G1 is promoted by the activity of the cyclin-dependent protein kinases CDK4 and CDK6 (ref. 2), which are inhibited by the protein p16INK4. We have isolated a new member of the p16INK4 family, p15INK4B. p15 expression is induced approximately 30-fold in human keratinocytes by treatment with TGF-beta, suggesting that p15 may act as an effector of TGF-beta-mediated cell cycle arrest. The gene encoding p15 is located on chromosome 9 adjacent to the p16 gene at a frequent site of chromosomal abnormality in human tumours (9p21).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition to p16INK4A, p15INK4B has been shown to an effector of TGF-β meditated cell cycle arrest by inhibiting CDK4/6 (Hannon and Beach, 1994).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Hannon and Beach, 1994
In the citing paper
“Within months of its discovery, the INK4a (CDKN2A) and the genetically linked INK4b gene (CDKN2B) (36) were implicated in a reverse genetic screen to play tumor suppressive roles in familial melanoma (37).”
From Targeting CDK4 and CDK6: From Discovery to Therapy (2016) · cites this paper as [36]
Citations
Cites
Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line.
Boukamp, P., Petrussevska, R. T., Breitkreutz, D., Hornung, J., Markham, A., & Fusenig, N. E. (1988) · The Journal of cell biology · doi:10.1083/jcb.106.3.761 · Cited by 4,170
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
The Transforming Growth Factor-beta Family
Massague, J. (1990) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.06.110190.003121 · Cited by 3,015
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
Polyak, K., Lee, M.-H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., & Massagué, J. (1994) · Cell · doi:10.1016/0092-8674(94)90572-x · Cited by 2,118
p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
Toyoshima, H., & Hunter, T. (1994) · Cell · doi:10.1016/0092-8674(94)90573-8 · Cited by 2,043
Sherr, C. J. (1993) · Cell · doi:10.1016/0092-8674(93)90636-5 · Cited by 1,960
Polyak, K., Kato, J. Y., Solomon, M. J., Sherr, C. J., Massague, J., Roberts, J. M., & Koff, A. (1994) · Genes & Development · doi:10.1101/gad.8.1.9 · Cited by 1,954
Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K., & Carson, D. A. (1994) · Nature · doi:10.1038/368753a0 · Cited by 1,742
Research works printed but not linked: 7
- Bates, S. et al. Oncogene 9, 71–79 (1994).
- Merlo, A., Gabrielson, E., Askin, F. & Sidransky, D. Cancer Res. 54, 640–642 (1994).
- Cheng, J. Q., Jhanwar, S. C., Lu, Y. Y. & Testa, J. R. Cancer Res. 53, 4761–4763 (1993).
- Petty, E. M. et al. Am. J. hum. Genet. 53, 96–104 (1993).
- Moses, H. L. et al. in Cancer Cells (eds Feramisco, J., Ozanne, B. & Stiles, C.) 3, 65–71 (1985).
- Manning, A. M., Williams, A. C., Gamie, S. M. & Paraskeva, C. Oncogene 6, 1471–1476 (1991).
- Rodeck, U. et al. Cancer Res. 54, 575–581 (1994).
Cited by
Items 201–300 of 1,003
The Retinoblastoma Protein: A Master Regulator of Cell Cycle, Differentiation and Apoptosis
Herwig, S., & Strauss, M. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.t01-2-00581.x · Cited by 250
The restriction point and control of cell proliferation
Planas-Silva, M. D., & Weinberg, R. A. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80076-2 · Cited by 250
Oertelt, S., Lian, Z.-X., Cheng, C.-M., Chuang, Y.-H., Padgett, K. A., He, X.-S., Ridgway, W. M., Ansari, A. A., Coppel, R. L., Li, M. O., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1655 · Cited by 248
Axin and GSK3-β control Smad3 protein stability and modulate TGF-β signaling
Guo, X., Ramirez, A., Waddell, D. S., Li, Z., Liu, X., & Wang, X.-F. (2008) · Genes & Development · doi:10.1101/gad.1590908 · Cited by 246
Identification of a Myc-dependent step during the formation of active G1 cyclin-cdk complexes.
Steiner, P., Philipp, A., Lukas, J., Godden-Kent, D., Pagano, M., Mittnacht, S., Bartek, J., & Eilers, M. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00163.x · Cited by 246
14-3-3 proteins associate with cdc25 phosphatases.
Conklin, D. S., Galaktionov, K., & Beach, D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7892 · Cited by 246
Li, J.-M., Nichols, M. A., Chandrasekharan, S., Xiong, Y., & Wang, X.-F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26750 · Cited by 246
Mysterious liaisons: the relationship between c-Myc and the cell cycle
Obaya, A. J., Mateyak, M. K., & Sedivy, J. M. (1999) · Oncogene · doi:10.1038/sj.onc.1202749 · Cited by 242
Id2 Specifically Alters Regulation of the Cell Cycle by Tumor Suppressor Proteins
Lasorella, A., Iavarone, A., & Israel, M. A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.6.2570 · Cited by 241
Control of the cell cycle and apoptosis
Lundberg, A. S., & Weinberg, R. A. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00292-0 · Cited by 216
McConnell, B. B., Gregory, F. J., Stott, F. J., Hara, E., & Peters, G. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1981 · Cited by 238
Mechanisms of action of flavopiridol
Sedlacek, H. H. (2001) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(00)00124-4 · Cited by 239
Genealogy, expression, and cellular function of transforming growth factor-β
Govinden, R., & Bhoola, K. D. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(03)00035-4 · Cited by 239
Potential Role of WAF1/Cip1/p21 as a Mediator of TGF-β Cytoinhibitory Effect
Li, C.-Y., Suardet, L., & Little, J. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.10.4971 · Cited by 239
Wu, H., Wade, M., Krall, L., Grisham, J., Xiong, Y., & Van Dyke, T. (1996) · Genes & Development · doi:10.1101/gad.10.3.245 · Cited by 234
Regulation of CDK/cyclin complexes during the cell cycle
Arellano, M., & Moreno, S. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(96)00178-1 · Cited by 236
Aging and microRNA expression in human skeletal muscle: a microarray and bioinformatics analysis
Drummond, M. J., McCarthy, J. J., Sinha, M., Spratt, H. M., Volpi, E., Esser, K. A., & Rasmussen, B. B. (2011) · Physiological Genomics · doi:10.1152/physiolgenomics.00148.2010 · Cited by 235
Poon, R. Y., Toyoshima, H., & Hunter, T. (1995) · Molecular Biology of the Cell · doi:10.1091/mbc.6.9.1197 · Cited by 234
Feng, X.-H., Liang, Y.-Y., Liang, M., Zhai, W., & Lin, X. (2002) · Molecular Cell · doi:10.1016/s1097-2765(01)00430-0 · Cited by 231
Yang, Z. Y., Simari, R. D., Perkins, N. D., San, H., Gordon, D., Nabel, G. J., & Nabel, E. G. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7905 · Cited by 232
Raf1 interaction with Cdc25 phosphatase ties mitogenic signal transduction to cell cycle activation.
Galaktionov, K., Jessus, C., & Beach, D. (1995) · Genes & Development · doi:10.1101/gad.9.9.1046 · Cited by 232
WELLER, M., & FONTANA, A. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(95)00010-0 · Cited by 230
Warner, B. J., Blain, S. W., Seoane, J., & Massagué, J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.5913 · Cited by 230
Inhibitory Effects of 1α,25-Dihydroxyvitamin D3 on the G1–S Phase-Controlling Machinery
Jensen, S. S., Madsen, M. W., Lukas, J., Binderup, L., & Bartek, J. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.8.0673 · Cited by 229
Inactivation of p16 in Human Mammary Epithelial Cells by CpG Island Methylation
Foster, S. A., Wong, D. J., Barrett, M. T., & Galloway, D. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.4.1793 · Cited by 229
TGF β Signaling in Tumor Initiation, Epithelial-to-Mesenchymal Transition, and Metastasis
Papageorgis, P. (2015) · Journal of Oncology · doi:10.1155/2015/587193 · Cited by 223
“[120] G.”
BackgroundFrederick, J. P., Liberati, N. T., Waddell, D. S., Shi, Y., & Wang, X.-F. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.6.2546-2559.2004 · Cited by 221
Edamoto, Y., Hara, A., Biernat, W., Terracciano, L., Cathomas, G., Riehle, H., Matsuda, M., Fujii, H., Scoazec, J., & Ohgaki, H. (2003) · International Journal of Cancer · doi:10.1002/ijc.11254 · Cited by 220
Pituitary Cytokine and Growth Factor Expression and Action
Ray, D., & Melmed, S. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.2.0297 · Cited by 220
A Genome-Wide Association Study of Optic Disc Parameters
Ramdas, W. D., van Koolwijk, L. M. E., Ikram, M. K., Jansonius, N. M., de Jong, P. T. V. M., Bergen, A. A. B., Isaacs, A., Amin, N., Aulchenko, Y. S., Wolfs, R. C. W., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000978 · Cited by 219
Sequence variants on chromosome 9p21.3 confer risk for atherosclerotic stroke
Gschwendtner, A., Bevan, S., Cole, J. W., Plourde, A., Matarin, M., Ross‐Adams, H., Meitinger, T., Wichmann, E., Mitchell, B. D., Furie, K., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21590 · Cited by 216
Transcriptional repression by Myc
Wanzel, M., Herold, S., & Eilers, M. (2003) · Trends in Cell Biology · doi:10.1016/s0962-8924(03)00003-5 · Cited by 216
Pedram, A., Razandi, M., & Levin, E. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26722 · Cited by 215
Apoptosis in Proliferating, Senescent, and Immortalized Keratinocytes
Chaturvedi, V., Qin, J.-Z., Denning, M. F., Choubey, D., Diaz, M. O., & Nickoloff, B. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.23358 · Cited by 215
Shen, X., Hu, P. P.-C., Liberati, N. T., Datto, M. B., Frederick, J. P., & Wang, X.-F. (1998) · Molecular Biology of the Cell · doi:10.1091/mbc.9.12.3309 · Cited by 215
“TGF- has been shown to cause cell cycle arrest by inhibiting the Cdk activities in certain cell types by inducing the expression of the two Cdk inhibitors p15 and p21 (Hannon and Beach, 1994; Datto et al., 1995a; Reynisdottir et al., 1995).”
BackgroundPark, M.-T., & Lee, S.-J. (2003) · BMB Reports · doi:10.5483/bmbrep.2003.36.1.060 · Cited by 200
“Its expression is induced in response to transforming-growth factor beta (TGF-β) treatment (Hannon and Beach, 1994).”
BackgroundBrotherton, D. H., Dhanaraj, V., Wick, S., Brizuela, L., Domaille, P. J., Volyanik, E., Xu, X., Parisini, E., Smith, B. O., Archer, S. J., et al. (1998) · Nature · doi:10.1038/26164 · Cited by 210
Rapamycin Resistance Tied to Defective Regulation of p27 Kip1
Luo, Y., Marx, S. O., Kiyokawa, H., Koff, A., Massagué, J., & Marks, A. R. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.12.6744 · Cited by 210
DeGregori, J., Leone, G., Ohtani, K., Miron, A., & Nevins, J. R. (1995) · Genes & Development · doi:10.1101/gad.9.23.2873 · Cited by 210
Responses of Normal Cells to Ionizing Radiation
Rodemann, H. P., & Blaese, M. A. (2007) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2006.11.005 · Cited by 208
Wiercinska, E., Naber, H. P. H., Pardali, E., van der Pluijm, G., van Dam, H., & ten Dijke, P. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1147-x · Cited by 208
(1998) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60740-x · Cited by 208
Wagner, M., Greten, F. R., Weber, C. K., Koschnick, S., Mattfeldt, T., Deppert, W., Kern, H., Adler, G., & Schmid, R. M. (2001) · Genes & Development · doi:10.1101/gad.184701 · Cited by 207
“The entry into the cell cycle is further controlled by the Ink4 protein family that includes p16Ink4a and the closely related p15Ink4b, p18Ink4c, and p19Ink4d proteins (Serrano et al. 1993; Guan et al. 1994; Hannon and Beach 1994; Chan et al. 1995).”
BackgroundRole of TGFβ in regulation of the tumor microenvironment and drug delivery (Review)
PAPAGEORGIS, P., & STYLIANOPOULOS, T. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2816 · Cited by 206
Tigan, A.-S., Bellutti, F., Kollmann, K., Tebb, G., & Sexl, V (2016) · Oncogene · doi:10.1038/onc.2015.407 · Cited by 204
Aprelikova, O., Xiong, Y., & Liu, E. T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.31.18195 · Cited by 203
Abrogation of p27 by cDNA Antisense Suppresses Quiescence (G0 State) in Fibroblasts
Rivard, N., L'Allemain, G., Bartek, J., & Pouysségur, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.31.18337 · Cited by 203
The cell cycle and acute kidney injury
Price, P. M., Safirstein, R. L., & Megyesi, J. (2009) · Kidney International · doi:10.1038/ki.2009.224 · Cited by 203
The GADD45 Inhibition of Cdc2 Kinase Correlates with GADD45-mediated Growth Suppression
Jin, S., Antinore, M. J., Lung, F.-D. T., Dong, X., Zhao, H., Fan, F., Colchagie, A. B., Blanck, P., Roller, P. P., Fornace, A. J., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000284200 · Cited by 202
TGF-β Function in Immune Suppression
Yoshimura, A., & Muto, G. (2010) · Current Topics in Microbiology and Immunology · doi:10.1007/82_2010_87 · Cited by 182
Transforming Growth Factor-β in the Gastrointestinal and Hepatic Tumor Microenvironment
Achyut, B. R., & Yang, L. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.048 · Cited by 199
Newt Myotubes Reenter the Cell Cycle by Phosphorylation of the Retinoblastoma Protein
Tanaka, E. M., Gann, A. A. F., Gates, P. B., & Brockes, J. P. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.136.1.155 · Cited by 199
“…of cyclin-dependent kinase inhibitors (CDIs) (Sherr and Roberts, 1995), which specifically bind to and inhibit CDK4 and 6 (Serrano et al., 1993; Hannon and Beach, 1994; Sheaff and Roberts, 1995; Koh et al., 1995). p16 INK4 can only inhibit entry to S phase or colony formation in cells that…”
BackgroundWong, I. H. N., Ng, M. H. L., Huang, D. P., & Lee, J. C. K. (2000) · Blood · doi:10.1182/blood.v95.6.1942 · Cited by 199
LIU, X., SUN, Y., WEINBERG, R., & LODISH, H. (2001) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00031-9 · Cited by 197
Miguchi, M., Hinoi, T., Shimomura, M., Adachi, T., Saito, Y., Niitsu, H., Kochi, M., Sada, H., Sotomaru, Y., Ikenoue, T., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0166422 · Cited by 194
Role of APC and DNA mismatch repair genes in the development of colorectal cancers.
Narayan, S., & Roy, D. (2003) · Molecular Cancer · doi:10.1186/1476-4598-2-41 · Cited by 254
Urı́a, J. A., Jiménez, M. G., Balbı́n, M., Freije, J. M. P., & López-Otı́n, C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.16.9769 · Cited by 194
Sandhu, C., Garbe, J., Bhattacharya, N., Daksis, J., Pan, C.-H., Yaswen, P., Koh, J., Slingerland, J. M., & Stampfer, M. R. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.5.2458 · Cited by 194
Recent progress in TGF-β inhibitors for cancer therapy
Huang, C.-Y., Chung, C.-L., Hu, T.-H., Chen, J.-J., Liu, P.-F., & Chen, C.-L. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111046 · Cited by 187
Transforming growth factor-β signal transduction in epithelial cells
Yue, J., & Mulder, K. M. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00143-7 · Cited by 193
Lee, M.-H., & Yang, H.-Y. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000826 · Cited by 192
Mechanisms of mitotic inhibition in corneal endothelium: contact inhibition and TGF-beta2.
Joyce, N. C., Harris, D. L., & Mello, D. M. (2002) · PubMed · Cited by 217
Regulation of the G1 phase of the mammalian cell cycle
DONJERKOVIC, D., & SCOTT, D. W. (2000) · Cell Research · doi:10.1038/sj.cr.7290031 · Cited by 190
Wong, I. H., Lo, Y. M., Yeo, W., Lau, W. Y., & Johnson, P. J. (2000) · PubMed · Cited by 190
Human T-Cell Leukemia Virus Type 1 Tax and Cell Cycle Progression: Role of Cyclin D-cdk and p110Rb
Neuveut, C., Low, K. G., Maldarelli, F., Schmitt, I., Majone, F., Grassmann, R., & Jeang, K.-T. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.6.3620 · Cited by 190
Matsumura, I., Ishikawa, J., Nakajima, K., Oritani, K., Tomiyama, Y., Miyagawa, J.-I., Kato, T., Miyazaki, H., Matsuzawa, Y., & Kanakura, Y. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.5.2933 · Cited by 190
Arendt, T. (2003) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2003.09.007 · Cited by 188
Hypermethylation of the CDKN2/p16 promoter during neoplastic progression in Barrett's esophagus
Klump, B., Hsieh, C.-J., Holzmann, K., Gregor, M., & Porschen, R. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70016-2 · Cited by 186
Basics of TGF-ß and Pancreatic Cancer
Truty, M. J., & Urrutia, R. (2007) · Pancreatology · doi:10.1159/000108959 · Cited by 185
Lu, S., Liu, M., Epner, D. E., Tsai, M., & Tsai, M. (1999) · Molecular Endocrinology · doi:10.1210/me.13.3.376 · Cited by 185
Mori, S., Matsuzaki, K., Yoshida, K., Furukawa, F., Tahashi, Y., Yamagata, H., Sekimoto, G., Seki, T., Matsui, H., Nishizawa, M., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207981 · Cited by 180
Small Molecules as Inhibitors of Cyclin‐Dependent Kinases
Huwe, A., Mazitschek, R., & Giannis, A. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200200540 · Cited by 181
Genestier, L., Kasibhatla, S., Brunner, T., & Green, D. R. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.2.231 · Cited by 177
The p21 cyclin–dependent kinase inhibitor suppresses tumorigenicity in vivo
Yang, Z.-Y., Perkins, N. D., Ohno, T., Nabel, E. G., & Nabel, G. J. (1995) · Nature Medicine · doi:10.1038/nm1095-1052 · Cited by 178
Christiansen, D. H., Andersen, M. K., & Pedersen-Bjergaard, J. (2003) · Leukemia · doi:10.1038/sj.leu.2403054 · Cited by 176
Cell cycle regulation by the retinoblastoma family of growth inhibitory proteins
Beijersbergen, R. L., & Bernards, R. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(96)00002-9 · Cited by 176
Parry, D., Mahony, D., Wills, K., & Lees, E. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1775 · Cited by 174
TGF-β, EMT, and resistance to anti-cancer treatment
Wang, X., Eichhorn, P. J. A., & Thiery, J. P. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.10.004 · Cited by 170
Cyclins and Cyclin-Dependent Kinases: Theme and Variations
(1995) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60254-7 · Cited by 172
Epidermal growth factor signaling via Ras controls the Smad transcriptional co-repressor TGIF
Lo, R. S. (2001) · The EMBO Journal · doi:10.1093/emboj/20.1.128 · Cited by 172
Poon, R. Y. C., Jiang, W., Toyoshima, H., & Hunter, T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.13283 · Cited by 172
Fåhraeus, R., Paramio, J. M., Ball, K. L., Laín, S., & Lane, D. P. (1996) · Current Biology · doi:10.1016/s0960-9822(02)00425-6 · Cited by 170
Biology and treatment of childhood T-lineage acute lymphoblastic leukemia.
Uckun, F. M., Sensel, M. G., Sun, L., Steinherz, P. G., Trigg, M. E., Heerema, N. A., Sather, H. N., Reaman, G. H., & Gaynon, P. S. (1998) · PubMed · doi:10.1182/blood.v91.3.735 · Cited by 171
Yu, J., Ni, M., Xu, J., Zhang, H., Gao, B., Gu, J., Chen, J., Zhang, L., Wu, M., Zhen, S., et al. (2002) · BMC Cancer · doi:10.1186/1471-2407-2-29 · Cited by 170
The tumour suppressor gene product APC blocks cell cycle progression from G0/G1 to S phase.
Baeg, G. H., Matsumine, A., Kuroda, T., Bhattacharjee, R. N., Miyashiro, I., Toyoshima, K., & Akiyama, T. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00249.x · Cited by 171
Stewart, Z. A., Leach, S. D., & Pietenpol, J. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.205 · Cited by 168
Alzheimer's disease as a disorder of mechanisms underlying structural brain self-organization
Arendt, T. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00516-9 · Cited by 169
Taniguchi, K., Kohsaka, H., Inoue, N., Terada, Y., Ito, H., Hirokawa, K., & Miyasaka, N. (1999) · Nature Medicine · doi:10.1038/10480 · Cited by 168
Kourea, H. P., Orlow, I., Scheithauer, B. W., Cordon-Cardo, C., & Woodruff, J. M. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65504-6 · Cited by 170
Riemondy, K. A., Jansing, N. L., Jiang, P., Redente, E. F., Gillen, A. E., Fu, R., Miller, A. J., Spence, J. R., Gerber, A. N., Hesselberth, J. R., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.123637 · Cited by 161
Updates on the CDK4/6 Inhibitory Strategy and Combinations in Breast Cancer
Sobhani, N., D’Angelo, A., Pittacolo, M., Roviello, G., Miccoli, A., Corona, S. P., Bernocchi, O., Generali, D., & Otto, T. (2019) · Cells · doi:10.3390/cells8040321 · Cited by 167
Inoue, K., & Sherr, C. J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.3.1590 · Cited by 168
Frequent Methylation Silencing of p15INK4b(MTS2) and p16INK4a (MTS1) in B-Cell and T-Cell Lymphomas
Baur, A. S., Shaw, P., Burri, N., Delacrétaz, F., Bosman, F. T., & Chaubert, P. (1999) · Blood · doi:10.1182/blood.v94.5.1773 · Cited by 165
Id3 inhibits B lymphocyte progenitor growth and survival in response to TGF-β
Kee, B. L., Rivera, R. R., & Murre, C. (2001) · Nature Immunology · doi:10.1038/85303 · Cited by 167
Role for BRG1 in Cell Cycle Control and Tumor Suppression
Hendricks, K. B., Shanahan, F., & Lees, E. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.1.362-376.2004 · Cited by 167
Kim, M. J., Park, B.-J., Kang, Y.-S., Kim, H. J., Park, J.-H., Kang, J. W., Lee, S. W., Han, J. M., Lee, H.-W., & Kim, S. (2003) · Nature Genetics · doi:10.1038/ng1182 · Cited by 165
Transforming growth factor-β signaling in normal and malignant hematopoiesis
Kim, S.-J., & Letterio, J. (2003) · Leukemia · doi:10.1038/sj.leu.2403069 · Cited by 166
p53-dependent repression of CDK4 translation in TGF-beta-induced G1 cell-cycle arrest.
Ewen, M. E., Oliver, C. J., Sluss, H. K., Miller, S. J., & Peeper, D. S. (1995) · Genes & Development · doi:10.1101/gad.9.2.204 · Cited by 166
Targeting CDK6 in cancer: State of the art and new insights
Tadesse, S., Yu, M., Kumarasiri, M., Le, B. T., & Wang, S. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1084445 · Cited by 163
Yoshida, K., Matsuzaki, K., Mori, S., Tahashi, Y., Yamagata, H., Furukawa, F., Seki, T., Nishizawa, M., Fujisawa, J., & Okazaki, K. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62324-3 · Cited by 165
Metadata
- Authors
- Hannon, G. J., & Beach, D.
- Affiliations
- Howard Hughes Medical Institute (US)
- ORCID
- Hannon, Gregory J.
- Venue
- Nature
- Published
- 1994-09
- Volume
- 371
- Issue
- 6494
- Pages
- 257-261
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2003907692
- Cited by
- 1,950
- References
- 29
- Citations by year
- 2026: 14 · 2025: 11 · 2024: 26 · 2023: 26 · 2022: 22 · 2021: 30 · 2020: 18 · 2019: 42 · 2018: 29 · 2017: 24 · 2016: 37 · 2015: 48 · 2014: 37 · 2013: 44 · 2012: 54
- FWCI
- 51.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- CDKN2B, p16INK4, TGF-beta, cell cycle arrest, G1 phase, CDK4, CDK6, cyclin-dependent kinases, keratinocytes, 9p21, tumor suppressor, chromosome 9
- MeSH terms
- Amino Acid Sequence, Base Sequence, Carrier Proteins, Cell Cycle, Cell Line, Cloning, Molecular, Humans, Molecular Sequence Data, Proto-Oncogene Proteins, RNA, Messenger, Keratinocytes, Gene Expression, Transforming Growth Factor beta, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Cyclin-Dependent Kinases, Cyclin-Dependent Kinase Inhibitor p16, Tumor Suppressor Proteins, Cyclin-Dependent Kinase Inhibitor p15, Cyclin-Dependent Kinase 4, Cyclin-Dependent Kinase 6
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.